In fact, GP9 has already been associated with neural-dysregulation and neurotoxicity, as aberrant expression of this gene has been measured in blood cells of Epilepsy and Multiple Sclerosis patients (Li et al. 2022; Berge et al. 2019). The gene discussed is GP9; the disease is multiple sclerosis.